THIS PRESS RELEASE IS NOT FOR GENERAL RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO, DIRECTLY OR INDIRECTLY, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD VIOLATE APPLICABLE LAWS OR REGULATIONS
GENEVA, April 4, 2024 /PRNewswire/ -- Firmenich International SA ("Firmenich") announces the Financial Statements for its fiscal year 2023, for the period ended 31 December 2023. The statements are available on investors.firmenich.com as well as dsm-firmenich.com.
Disclosure
The information was submitted for publication, through the contact persons set out below, at 07:00 CEST on 4 April 2024. Further information is available on investors.firmenich.com and dsm-firmenich.com.
ENDS
Contacts
Firmenich Ingvild Van Lysebetten Email: ingvild.van.lysebetten@dsm-firmenich.com |
Robin Roothans Email: robin.roothans@dsm-firmenich.com |
About Firmenich
Firmenich International SA announced on 9 May 2023 the completion of its merger with DSM to establish DSM-Firmenich AG, the leading innovation partner in nutrition, health, and beauty. Prior to the merger, Firmenich was the world's largest privately-owned fragrance and taste company. It was founded in Geneva, Switzerland, in 1895, and family-owned for 128 years. Firmenich was a business-to-business company specialized in the research, creation, manufacture and sale of perfumes, flavors, and ingredients. Renowned for its excellent research, as well as its leadership in sustainability, Firmenich offered its customers innovation in formulation, a broad palette of ingredients, and proprietary technologies such as biotechnology.
Legal information
This press release is provided purely for informational purposes and is expressly not directed at persons whose nationality or place of residence prohibits access to such information on account of existing legislation. The information and views contained in it do not constitute a request, offer, or recommendation to use a service, to buy or sell investment instruments, or to conduct other transactions. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. Forward-looking statements, by their nature, involve general and specific risks and uncertainties. It should be noted that there is a risk that forecasts, predictions, projections, and results described or implied in forward-looking statements may not prove to be correct.
PDF - https://mma.prnewswire.com/media/2379029/Combined_Firmenich_Annual_report_Dec_23.pdf
Logo - https://mma.prnewswire.com/media/2167572/4630639/FIRMENICH_Logo.jpg
